3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Common Wart: new trials by email Literature Review of Common Wart trials Research Report on Common Wart
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of A-101 Topical Solution for the Treatment of Common Warts A-101 - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 426 | 2019-02-07 | 2020-11-23 |
| Study of A-101 Topical Solution for the Treatment of Common Warts A-101, vehicle - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 503 | 2018-09-17 | 2020-10-05 |
| A Study of A-101 Topical Solution for the Treatment of Common Warts Active, Vehicle - Common Wart | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 502 | 2018-09-13 | 2020-10-27 |
Warts (3)
DNA Virus Infections (3) · Infections (3) · Papillomavirus Infections (3) · Skin Diseases (3) · Skin Diseases, Infectious (3) · Skin Diseases, Viral (3) · Skin and Connective Tissue Diseases (3) · Tumor Virus Infections (3) · Virus Diseases (3)
2-Propanol (2) · N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (2) · Exercise (1)
Aclaris Therapeutics, Inc. (3)
United States (3)
David Gordon, MB, ChB (1) · Judy Schynder (1)